Non-linearity within the primary measurement range of a lipase assay as the cause of a gap in the interpatient lipase results distribution

Ashley N. Vogel, Barbara M. Goldsmith, Mark A. Marzinke, Lori J. Sokoll, Douglas F. Stickle

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Objectives: Interpatient distribution data for lipase (Roche Cobas® assay) showed an unexpected data gap, where no results were reported. This gap occurred beginning at a point just above the assay's primary measurement range (i.e., above the cutoff (300 U/L) for automated repeat-on-dilution). Calculation or other errors within the automated dilution process were ruled out. Linearity of assay results was investigated. Design and methods: Linearity of experimental sample dilution series data was assessed by correlation coefficient, intercept, and constancy of slope. Results: Dilution experiment data demonstrated a discontinuity of results between 300 and 400 U/L consistent with the observed gap in patient data. Although data within the presumed linear range of the assay had a high linear correlation coefficient (r2 > 0.99), a non-zero intercept and progressively variable slope were inconsistent with linearity. Although the assay was assessed as linear by the College of American Pathology linearity survey, survey data also demonstrated non-linearity for this assay when analyzed for slopes and intercept. Conclusions: Non-linearity in the presumed linear range of an assay can produce gaps in patient data above a repeat-on-dilution cutoff. As in this instance, CAP linearity surveys may not identify certain forms of non-linearity.

Original languageEnglish (US)
Pages (from-to)176-179
Number of pages4
JournalClinical Biochemistry
Volume49
Issue number1
DOIs
StatePublished - Jan 1 2016

Keywords

  • Linearity
  • Lipase
  • Proficiency testing
  • Quality assurance

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Non-linearity within the primary measurement range of a lipase assay as the cause of a gap in the interpatient lipase results distribution'. Together they form a unique fingerprint.

Cite this